Keywords: ibex, neutralase, phase, testing, technologies, commenced, trial

IBEX' Neutralase In Phase I Testing

Article | 05 June 1995

Print This

IBEX Technologies has commenced a Phase I trial of its lead compound Neutralase (heparinase I), which is intended for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in